MDP Veterinary News
The veterinary and animal-health sectors are evolving rapidly, driven by advances in science, shifting regulatory expectations, and growing convergence between veterinary and human medical innovation.
From comparative oncology and advanced diagnostics to manufacturing quality, supply-chain integrity, and regulatory enforcement, developments in animal health increasingly carry implications well beyond the veterinary clinic.
MDP’s Veterinary News provides curated, professional-grade coverage of issues shaping the veterinary and animal-health landscape.
Our focus is on developments that matter to manufacturers, researchers, regulators, investors, and quality and regulatory professionals working in FDA- and USDA-regulated environments.
Coverage includes:
-
- Veterinary drug and device regulatory updates
- Quality system and compliance trends
- Recalls, enforcement actions, and safety communications
- Translational research with human health implications
- Manufacturing, supply-chain, and post-market considerations
This page is intended to inform professionals – not to provide medical advice or replace clinical judgment.
Our goal is to connect scientific and regulatory developments with practical insight, helping stakeholders understand what is changing, why it matters, and how it may affect regulated veterinary products and programs.
FDA Approves First Generic for Bovine Respiratory Disease
nixiFLOR, the first generic version of Resflor GOLD The U.S. Food and Drug Administration has approved nixiFLOR, an injectable solution combining florfenicol and flunixin meglumine, for the treatment of bovine respiratory disease (BRD) and the control of...
FDA Approves Drug to Delay Canine Congestive Heart Failure
Vetmedin is the first drug to go from an expanded conditional approval to fully approved The U.S. Food and Drug Administration has fully approved a new use for Vetmedin (pimobendan) chewable tablets, making it the first drug officially recognized to delay the onset of...
FDA Completes Risk Review of Canine Freeze-Dried Plasma
Freeze-Dried Plasma for Emergency Use in Dogs The U.S. Food and Drug Administration (FDA) has completed a risk review of Mantel’s Canine Freeze-Dried Plasma (cFDP), a pooled allogeneic canine plasma product intended for the treatment of hypovolemia and control of...
Canine microRNA Biomarkers and Osteosarcoma Diagnostics
The Diagnostic Problem Despite advances in surgery and chemotherapy, survival outcomes for osteosarcoma have changed little in more than 30 years – largely because metastasis is detected too late. Current diagnostics rely on imaging (often after spread has occurred),...
Canine Osteosarcoma Immunotherapy and Human Research
Osteosarcoma Osteosarcoma is a devastating bone cancer with limited treatment progress over decades. In humans, it remains rare but deadly – striking roughly 1,000 Americans each year, often children and adolescents. It is tragically common in dogs, with an estimated...
FDA Approves First Generic for Bovine Respiratory Disease
nixiFLOR, the first generic version of Resflor GOLD The U.S. Food and Drug Administration has approved nixiFLOR, an...
FDA Approves Drug to Delay Canine Congestive Heart Failure
Vetmedin is the first drug to go from an expanded conditional approval to fully approved The U.S. Food and Drug...
FDA Completes Risk Review of Canine Freeze-Dried Plasma
Freeze-Dried Plasma for Emergency Use in Dogs The U.S. Food and Drug Administration (FDA) has completed a risk review of...
Canine microRNA Biomarkers and Osteosarcoma Diagnostics
The Diagnostic Problem Despite advances in surgery and chemotherapy, survival outcomes for osteosarcoma have changed little...
Canine Osteosarcoma Immunotherapy and Human Research
Osteosarcoma Osteosarcoma is a devastating bone cancer with limited treatment progress over decades. In humans, it remains...